Zenas BioPharma Aktie
WKN DE: A40MUX / ISIN: US98937L1052
17.03.2025 12:25:49
|
Zenas BioPharma Appoints Lisa Von Moltke As CMO
(RTTNews) - Zenas BioPharma, Inc. (ZBIO), Monday announced the appointment of Lisa von Moltke as the company's Head of Research and Development and Chief Medical Officer.
Most recently, von Moltke served as CMO at Seres Therapeutics with functional oversight of clinical development, sciences and operations, and regulatory and medical affairs.
Friday, Zenas's stock closed at $8.25, down 5.50 percent on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Zenas BioPharma Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Zenas BioPharma Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Zenas BioPharma Inc Registered Shs | 8,17 | 1,74% |
|